Dihydroergotamine

Records for this ingredient, by country (identity only).

ATC N02CA01 · 4 markets · 22 records

Dihydroergotamine 4 markets · 22 records Forms
Filters

US 15 records · 3 shown of 3 Source openFDA NDC Directory · Data as of 2026-10-23

  • 4 mgtopicalTrudhesaManufacturer: Advagen Pharma Ltd、Manufacturer: Cipla USA Inc.、Manufacturer: Hikma Pharmaceuticals USA I…、Manufacturer: Oceanside Pharmaceuticals、Manufacturer: Somerset Therapeutics, LLC、Manufacturer: Trifluent Pharma, LLC
  • 1 mg per mL / per unit basis not statedinjectionBREKIYAManufacturer: Baxter Healthcare Corporati…、Manufacturer: Gland Pharma Limited、Manufacturer: Hikma Pharmaceuticals USA I…、Manufacturer: Milla Pharmaceuticals Inc.、Manufacturer: Provepharm Inc.
  • 5.2 mgpowderATZUMI

CA 2 records · 2 shown of 2 Source Health Canada Drug Product Databas · Data as of 2026-10-23

  • 1 mg per mL / per unit basis not statedliquidDIHYDROERGOTAMINE
  • 0.5 mg per mL / per unit basis not statedliquidMIGRANAL

GB 1 records · 1 shown of 1 Source NHSBSA dm+d · Data as of 2026-10-19

  • 1 mg/1 mLinjectionManufacturer: Imported (Canada)

FR 1 records · 1 shown of 1 Source Base de données publique des médic · Data as of 2026-11-03

  • 4 mg per mL / per unit basis not statedliquidDIERGOSPRAY 4 mg/ml, solution pour pulvérisation nasale

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.